A Clinical Study to Assess the Efficacy and Safety of SED80 for Use in Cataract Surgery

A Phase 2 Clinical Study to Assess the Efficacy and Safety of SED80 for the Treatment of Inflammation and Pain Associated With Cataract Surgery

Patients at least 40 years of age who are undergoing cataract surgery will be randomized to receive treatment with one of four groups of dexamethasone ophthalmic suspension or placebo eye drops to determine if the drops decrease inflammation and pain inside the eye and are safe after cataract surgery.

"Patients undergoing traditional cataract surgery routinely develop inflammation and pain. This study will evaluate 4 arms of either dexamethasone or placebo.

Inclusion Criteria:

• Patients undergoing traditional cataract surgery.

Exclusion Criteria:

• Patients with unusual ocular conditions.